Unquote Private Equity Podcast: Covid-19 special
The Unquote team gathers for its first remote podcast, discussing how the early stages of the coronavirus outbreak have disrupted the European private equity landscape.
The private equity industry is shifting its strategy to cope with the deadly coronavirus pandemic, delaying deals and fortifying their portfolios to weather the sharpest downturn in generations. Unquote editor Greg Gille gives an overview of the situation across Europe and later hosts senior reporter Alessia Argentieri and reporter Katharine Hidalgo to hear how GPs have reacted in southern Europe and the UK.
0:00 – Intro
1:29 – General overview
7:53 – Southern Europe in crisis mode
18:28 – UK scrambles to adapt
Note: this episode was recorded and edited prior to the sale process for the UK's Asda falling through as well.
Theme music: ©2012 Kick Up The Fire
You can listen to the podcast in the audio player above, as well as your favourite podcasting platforms, including Spotify and Apple Podcasts.
More on Industry
Sovereign appoints Rossetti to investment team
Rossetti previously worked at Morgenthaler Private Equity and Incline Equity Partners
Commercial due diligence: Adapting to the new landscape
Three CDD practitioners discuss dealflow, and how their offering is shifting as PE houses contemplate post-Covid scenarios
KKR commits $1bn for GTR formation
Investment will be supported by $1.5bn in debt financing for a buy-and-build startegy
Unquote Private Equity Podcast: Back for secondaries
When activity begins again, will LPs be willing to take a pricing hit? And where will buyer and seller expectations meet?
Latest News
Plastic alternative producer Lactips raises €13m
Company has raised €20m so far over two funding rounds
Ping An Global leads €32m funding round for PlusDental
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK closes ninth-generation fund on €2.85bn
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
ArchiMed's Bomi bolts on Logifarma
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy
